batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Boehringer’s latest conjugate deal rings some old bells 16 October 2025 Few pancreatic Gleams of hope for Vyloy 15 October 2025 Pfizer looks for Tukysa maintenance 14 October 2025 Another bump in Moderna’s neoantigen road 13 October 2025 Competition crowds out Torl's conjugate efforts 10 October 2025 Bristol is next into in vivo Car-T 10 October 2025 Questions mount for Eisai's Elahere wannabe 10 October 2025 PD-L1 degraders emerge 9 October 2025 Load More